Subgroup | Number of tumours | Hormonal status | Age | Tumour size | Lymph node status | Histological grade (SBR) | Clinical outcome | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
n | % ER+ | % ER- | % <50 years | % pT1 | % pT2-3 | % pN0 | % pN1 | % SBRI | % SBRII | % SBRIII | % recurrence | |
1 | 8 | 88 | 12 | 13 | 38 | 50 | 38 | 50 | 25 | 75 | 0 | 25 |
2 | 12 | 100 | 0 | 8 | 25 | 75 | 67 | 17 | 25 | 58 | 17 | 8 |
3/4 | 38 | 95 | 5 | 11 | 21 | 76 | 53 | 42 | 8 | 74 | 16 | 13 |
5 | 5 | 80 | 20 | 0 | 20 | 80 | 60 | 40 | 20 | 80 | 0 | 0 |
6 | 5 | 40 | 60 | 0 | 20 | 80 | 60 | 40 | 40 | 40 | 20 | 20 |
7 | 19 | 74 | 26 | 37 | 53 | 42 | 47 | 42 | 53 | 47 | 0 | 0 |
9 | 10 | 50 | 50 | 10 | 40 | 60 | 50 | 50 | 0 | 10 | 90 | 20 |
10 | 21 | 10 | 90 | 29 | 24 | 71 | 57 | 43 | 5 | 5 | 86 | 29 |
12 | 3 | 100 | 0 | 67 | 0 | 100 | 67 | 33 | 0 | 33 | 67 | 33 |
Overall cohort | 121 | 70 | 30 | 18 | 29 | 68 | 54 | 40 | 18 | 49 | 31 | 15 |